Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Marc-Andre Marcotte
AddedFeb 15, 2024
UpdatedMay 31, 2026
Marc-Andre Marcotte

Marc-Andre Marcotte

Board Member, CurvaFix

Crunchbase

Marc-Andre Marcotte's Career

CurvaFix
CurvaFix

Bellevue, WA, US

Board Member· Board
Cagent Vascular
Cagent Vascular

Wayne, PA, US

Board Member· Board
Neuros Medical
Neuros Medical

Willoughby Hills, OH, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Marc-Andre Marcotte's Career

CurvaFix
CurvaFix
Series C$60.2M232013Bellevue, WA, US
Board Member· Board

Leadership at CurvaFix

Trevor MoodyTrevor MoodyBoard Member
Steve DimmerSteve DimmerCEO
Eric BellEric BellBoard Member
Thomas KangThomas KangBoard Member
Cagent Vascular
Cagent Vascular
Series A$21.9M412014Wayne, PA, US
Board Member· Board

Leadership at Cagent Vascular

Dennis M. McGrathDennis M. McGrathBoard Member
Peter JohanssonPeter JohanssonCo-Founder
Peter SchneiderPeter SchneiderCo-Founder
Llewellyn LeeLlewellyn LeeBoard Member
Robert GiasolliRobert GiasolliCo-Founder
Carol BurnsCarol BurnsCo-Founder

Similar to Cagent Vascular

Advanced Catheter TherapiesAdvanced Catheter TherapiesChattanooga, TN, USMedical Devicesest. 2008Advanced Catheter TherapiesChattanooga, TN, US · est. 2008

ACT develops innovative catheter technologies and devices for vascular disease treatment and prevention.

Series A · $14.2M5
Traverse VascularTraverse VascularSolana Beach, CA, USMedical Devicesest. 2019Traverse VascularSolana Beach, CA, US · est. 2019

Traverse Vascular: Innovating chronic total occlusions treatment with breakthrough medical devices since 2019.

Pre-Seed · $1.1M1
Cross VascularCross VascularSolana Beach, CA, USMedical Devicesest. 2020Cross VascularSolana Beach, CA, US · est. 2020

Cross Vascular: A Solana Beach-based medical device company innovating in cardiovascular technologies since 2020.

Series A · $3.5M1
Bluegrass Vascular TechnologiesBluegrass Vascular TechnologiesSan Antonio, TX, USMedical Devicesest. 2011Bluegrass Vascular TechnologiesSan Antonio, TX, US · est. 2011

Bluegrass Vascular Technologies: Innovating lifesaving vascular access devices and methods.

Series A · $4.5M6
Neuros Medical
Neuros Medical
Public$113.7M412008Willoughby Hills, OH, US
Board Member· Board

Leadership at Neuros Medical

Tom WilderTom WilderCEO
Alan KaganovAlan KaganovBoard Member
Anthony NataleAnthony NataleBoard Member
Jon SnyderJon SnyderFounder
Casey TanseyCasey TanseyBoard Member
Clay RankinClay RankinBoard Member

Marc-Andre Marcotte's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Marc-Andre Marcotte

Mark NeporentMark NeporentBoard Member · MCIJody VandergriffJody VandergriffBoard Member · SightworthyRyan ZachariaRyan ZachariaBoard Member · Core10Colin BryantColin BryantBoard Member · WaterbitDavid CahnDavid CahnBoard Member · Abacus.AIJarrett LilienJarrett LilienFounder · Bendigo Partners